P945: REAL-WORLD CLINICAL OUTCOMES AMONG TRIPLE-CLASS EXPOSED RELAPSED REFRACTORY MULTIPLE MYELOMA PATIENTS IN US AND EUROPE: A PREAMBLE REGISTRY STUDY

• Karthik Ramasamy,
• Hartmut Goldschmidt,
• Philippe Moreau,
• Maria-Teresa Petrucci,
• David Kuter,
• Brian Durie,
• David Cella,
• Devender Dhanda,
• Jin Gu,
• Suvina Amin,
• Thomas Marshall,
• Pallavi Patwardhan,
• Susan Fish,
• Ravi Vij

Affiliations

Karthik Ramasamy

1 Department of Haematology, Oxford University Hospitals NHS Trust, Oxford, United Kingdom

Hartmut Goldschmidt

2 Sektion Multiples Myelom der Medizinischen Klinik V und des Nationalen Centrums für Tumorerkrankungen (NCT), Heidelberg, Germany

Philippe Moreau

3 Hematology Department University Hospital Hôtel-Dieu, Nantes, France

Maria-Teresa Petrucci

4 OU Policlinico Umberto I, Rome, Italy

David Kuter

5 Center for Hematology, Massachusetts General Hospital Cancer Center, Boston, MA, United States

Brian Durie

6 Department of Hematology/Oncology, Cedars-Sinai Medical Center, Los Angeles, CA, United States

David Cella

7 Northwestern University Feinberg School of Medicine, Chicago, IL, United States

Devender Dhanda

8 Bristol Myers Squibb, Princeton, NJ, United States

Jin Gu

8 Bristol Myers Squibb, Princeton, NJ, United States

Suvina Amin

8 Bristol Myers Squibb, Princeton, NJ, United States

Thomas Marshall

8 Bristol Myers Squibb, Princeton, NJ, United States

Pallavi Patwardhan

8 Bristol Myers Squibb, Princeton, NJ, United States

Susan Fish

8 Bristol Myers Squibb, Princeton, NJ, United States

Ravi Vij

9 Washington University School of Medicine, Division of Oncology, St. Louis, MO, United States